» Articles » PMID: 30559254

Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies

Overview
Specialty General Medicine
Date 2018 Dec 19
PMID 30559254
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Ototoxicity refers to damage of inner ear structures (i.e., the cochlea and vestibule) and their function (hearing and balance) following exposure to specific in-hospital medications (i.e., aminoglycoside antibiotics, platinum-based drugs), as well as a variety of environmental or occupational exposures (e.g., metals and solvents). This review provides a narrative derived from relevant papers describing factors contributing to (or increasing the risk of) aminoglycoside and cisplatin-induced ototoxicity. We also review current strategies to protect against ototoxicity induced by these indispensable pharmacotherapeutic treatments for life-threatening infections and solid tumors. We end by highlighting several interventional strategies that are currently in development, as well as the diverse challenges that still need to be overcome to prevent drug-induced hearing loss.

Citing Articles

Ferroptosis and hearing loss: from molecular mechanisms to therapeutic interventions.

Lv X, Yang C, Li X, Liu Y, Yang Y, Jin T J Enzyme Inhib Med Chem. 2025; 40(1):2468853.

PMID: 39992186 PMC: 11852237. DOI: 10.1080/14756366.2025.2468853.


Protective effects of MET channels on aminoglycosides- and cisplatin-induced ototoxicity.

Ouyang L, Ma L, Feng Y Int J Med Sci. 2025; 22(3):732-744.

PMID: 39898250 PMC: 11783074. DOI: 10.7150/ijms.103270.


Berberrubine protects against cisplatin-induced ototoxicity by promoting folate biosynthesis.

Miao Z, Chang D, Du X, Sun C Front Pharmacol. 2025; 15():1496917.

PMID: 39850559 PMC: 11754208. DOI: 10.3389/fphar.2024.1496917.


Hearing modulation affects Alzheimer's disease progression linked to brain inflammation: a study in mouse models.

Ko Y, Ryu Y, Han S, Park H, Choi M, Kim B Mol Med. 2024; 30(1):276.

PMID: 39725872 PMC: 11670416. DOI: 10.1186/s10020-024-01040-1.


Inhibition of the cGAS‑STING Pathway Reduces Cisplatin-Induced Inner Ear Hair Cell Damage.

Sun Y, Zou S, Xu X, Xu S, Sun H, Tang M Neurosci Bull. 2024; 41(3):359-373.

PMID: 39676140 PMC: 11876498. DOI: 10.1007/s12264-024-01334-8.


References
1.
Teitz T, Fang J, Goktug A, Bonga J, Diao S, Hazlitt R . CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss. J Exp Med. 2018; 215(4):1187-1203. PMC: 5881471. DOI: 10.1084/jem.20172246. View

2.
Siddik Z . Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003; 22(47):7265-79. DOI: 10.1038/sj.onc.1206933. View

3.
Karasawa T, Sibrian-Vazquez M, Strongin R, Steyger P . Identification of cisplatin-binding proteins using agarose conjugates of platinum compounds. PLoS One. 2013; 8(6):e66220. PMC: 3670892. DOI: 10.1371/journal.pone.0066220. View

4.
van Ruijven M, de Groot J, Hendriksen F, Smoorenburg G . Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs. Hear Res. 2005; 203(1-2):112-21. DOI: 10.1016/j.heares.2004.12.007. View

5.
Clemens E, de Vries A, Pluijm S, Am Zehnhoff-Dinnesen A, Tissing W, Loonen J . Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study. Eur J Cancer. 2016; 69:77-85. DOI: 10.1016/j.ejca.2016.09.023. View